Health
ImmunoGen’s Rare Blood Cancer Candidate Gets Breakthrough Tag
ImmunoGen, Inc. IMGN announced that the FDA has granted a Breakthrough Therapy designation to its novel CD123-targeted antibody-drug conjugate (ADC) IMGN632 for the treatment of patients with relapsed/refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN), a ... [Read]
Biotechnology
New Ventures Funds Rebrands as Scientia Ventures
NEW-VENTURES-rebrands PR Newswire NEW YORK, Oct. 2, 2020 NEW YORK , Oct. 2, 2020 /PRNewswire/ — New Ventures Funds has launched a new corporate brand identity and changed its name to Scientia Ventures. The new ... [Read]
Health
Ironwood to End IW-3718 Development After Study Failure
Ironwood Pharmaceuticals, Inc. IRWD announced that its pipeline candidate, IW-3718, failed to meet primary endpoint in one of the two identical phase III studies, evaluating it in refractory gastroesophageal reflux disease (“GERD”) patients following a ... [Read]
Else Nutrition Holdings Inc-PR
Else Nutrition Announces $10 Million Bought Deal and Concurrent up to $5 million Private Placement
/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, Sept. 15, 2020 /CNW/ – Else Nutrition Holdings Inc. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the ... [Read]
Else Nutrition Holdings Inc-PR
Else Nutrition Announces $10 Million Bought Deal and Concurrent up to $5 million Private Placement
/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, Sept. 15, 2020 /CNW/ – Else Nutrition Holdings Inc. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or ... [Read]
CloudMD-PR
CloudMD to Acquire iMD Health Global Corp., a Revolutionary Patient Engagement Software Company
Award-winning patient engagement software providing peer- reviewed, educational resources for patients about their conditions and treatment plans Access to 7.5 million patients, with over 10,000 healthcare professionals and other users, and 60 healthcare associations globally ... [Read]
Biotechnology
Ascendis Pharma A/S Announces Participation at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference
COPENHAGEN, Denmark, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that the company will participate in ... [Read]
Health
Generation X Investors: Deja Vu?
(0:45) – August’s Booming Market: Is It Another Dot Com Bubble? (11:00) – Breaking Down Large Cap Pharma and Energy Stocks (19:40) – Weak Small Cap Stocks: Where Is A Good Place To Invest? ... [Read]
CloudMD-PR
CloudMD Appoints Experienced, World-Class Insurance and Health Executive as Chief Innovation Officer
Karen Adams brings over 20 years’ experience leading large public and private insurance and mental health and wellness companies VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV:DOC)(OTCQB:DOCRF)(Frankfurt: 6PH) ... [Read]
Biotechnology
Bluebird (BLUE) Down 7.8% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Bluebird Bio (BLUE). Shares have lost about 7.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ... [Read]